Brigit Biofarmaka Teknologi Tbk. vs Wira Global Solusi Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume), while Wira Global Solusi Tbk. trades at Rp195 (market cap 385.73B, 34.21M 24h volume). The key difference: Wira Global Solusi Tbk. is far larger — about 2.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Wira Global Solusi Tbk. is more actively traded (34.21M versus 62.5K). Which is the better fit depends on your goals.
| OBAT | WGSH | |
|---|---|---|
Market Cap | 164.65B | 385.73B |
Volume | 62.5K | 34.21M |
Lot | 625 | 342.09K |
Turnover | 15.03M | 6.51B |
Average Price | 240.55 | 190.22 |
Value | 15.03M | 6.51B |
Indicative Equilibrium Price | 238 | 195 |
Indicative Equilibrium Volume | 100 | 5.78K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Wira Global Solusi Tbk (the Company) was established under name PT Gcloud Teknologi Informasi based on Deed No. 5 dated September 7, 2015 of Bhuana Nurinsani, S.H., notary in Bandung. Ikin Wirawan is the ultimate beneficial owner and controlling shareholder of the Company.
Read more on WGSH →